Login / Signup

Effect of CMV Mismatch on Heart Transplant Outcomes Using a Surveillance and Preemptive Strategy.

Guy A MacGowanJulie SamuelAdam McDiarmidOscar Gonzalez-FernandezGareth Parry
Published in: Clinical transplantation (2024)
There is no significant increased mortality or morbidity using a CMV surveillance and preemptive therapy protocol. The effect of donor age on seroconversion of mismatches requires further validation.
Keyphrases
  • public health
  • randomized controlled trial
  • heart failure
  • cardiovascular events
  • risk factors
  • atrial fibrillation
  • type diabetes
  • cardiovascular disease
  • stem cells
  • adipose tissue
  • skeletal muscle
  • postoperative pain